Used in the synthesis of pharmaceutical intermediates, particularly in the development of carbonic anhydrase inhibitors. It serves as a key building block for sulfonamide-based drugs, which are applied in treating glaucoma, epilepsy, and certain types of hypertension. Its structure allows for effective binding to enzyme active sites, enhancing therapeutic efficacy. Also explored in prodrug designs to improve drug solubility and bioavailability.